Literature DB >> 9041206

Generation and genetic characterization of immortal human prostate epithelial cell lines derived from primary cancer specimens.

R K Bright1, C D Vocke, M R Emmert-Buck, P H Duray, D Solomon, P Fetsch, J S Rhim, W M Linehan, S L Topalian.   

Abstract

Difficulty in establishing long-term human prostate epithelial cell lines has impeded efforts to understand prostate tumorigenesis and to develop alternative therapies for prostate cancer. In the current study, we describe a method that was successful in generating 14 immortal benign or malignant prostate epithelial cell cultures from primary adenocarcinomas of the prostate resected from six successive patients. Immortalization with the E6 and E7 transforming proteins of human papilloma virus serotype 16 was necessary to establish long-term cultures. Microscopic examination of fresh tumor specimens exhibited a variable mixture of benign and malignant epithelium. Thus, single-cell cloning of tumor-derived cell cultures was essential for defining tumor cell lines. Efforts to characterize these cultures using traditional criteria such as karyotype, growth in nude mice, and prostate-specific antigen expression were noninformative. However, allelic loss of heterozygosity (LOH) represents a powerful alternative method for characterizing tumor cell lines originating from primary adenocarcinomas of the prostate. Microdissected fresh tumors from four of six patients revealed LOH at multiple loci on chromosome 8p, as assessed by PCR. LOH on chromosome 8p matching the patterns found in microdissected tumors was also observed in a tumor-derived cell line and its clones, as well as in one clone from a tumor-derived cell line from a second patient. LOH was not observed in immortal lines generated from autologous benign prostatic epithelium, seminal vesicle epithelium, or fibroblasts. The multifocal nature of prostate cancer, as well as the presence of an entire spectrum of malignant transformation within individual prostate glands, necessitates this type of careful analysis of derivative cell cultures for their validation as in vitro models that accurately reflect the primary cancers from which they are derived.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9041206

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  23 in total

1.  Studies on the influence of DNA repair on radiosensitivity in prostate cell lines.

Authors:  Antonio M Serafin; John M Akudugu; Lothar Böhm
Journal:  Urol Res       Date:  2003-04-01

2.  Critical role of O-Linked β-N-acetylglucosamine transferase in prostate cancer invasion, angiogenesis, and metastasis.

Authors:  Thomas P Lynch; Christina M Ferrer; S RaElle Jackson; Kristina S Shahriari; Keith Vosseller; Mauricio J Reginato
Journal:  J Biol Chem       Date:  2012-01-24       Impact factor: 5.157

3.  Critical and distinct roles of p16 and telomerase in regulating the proliferative life span of normal human prostate epithelial progenitor cells.

Authors:  Bobby Bhatia; Ming Jiang; Mahipal Suraneni; Lubna Patrawala; Mark Badeaux; Robin Schneider-Broussard; Asha S Multani; Collene R Jeter; Tammy Calhoun-Davis; Limei Hu; Jianhua Hu; Spiridon Tsavachidis; Wei Zhang; Sandy Chang; Simon W Hayward; Dean G Tang
Journal:  J Biol Chem       Date:  2008-07-28       Impact factor: 5.157

4.  Focal adhesion kinase (FAK) phosphorylation is not required for genistein-induced FAK-beta-1-integrin complex formation.

Authors:  Y Liu; E Kyle; R Lieberman; J Crowell; G Kellof; R C Bergan
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

5.  Regulation of androgen receptor-dependent transcription by coactivator MED1 is mediated through a newly discovered noncanonical binding motif.

Authors:  Feng Jin; Frank Claessens; Joseph D Fondell
Journal:  J Biol Chem       Date:  2011-11-18       Impact factor: 5.157

6.  PAK4: a pluripotent kinase that regulates prostate cancer cell adhesion.

Authors:  Claire M Wells; Andrew D Whale; Maddy Parsons; John R W Masters; Gareth E Jones
Journal:  J Cell Sci       Date:  2010-04-20       Impact factor: 5.285

7.  A novel role for Wnt/Ca2+ signaling in actin cytoskeleton remodeling and cell motility in prostate cancer.

Authors:  Qin Wang; Andrew J Symes; Corrina A Kane; Alex Freeman; Joseph Nariculam; Philippa Munson; Christopher Thrasivoulou; John R W Masters; Aamir Ahmed
Journal:  PLoS One       Date:  2010-05-04       Impact factor: 3.240

8.  A regulatory role for Sec tRNA[Ser]Sec in selenoprotein synthesis.

Authors:  Ruth R Jameson; Alan M Diamond
Journal:  RNA       Date:  2004-07       Impact factor: 4.942

9.  Interferon-gamma reduces cell surface expression of annexin 2 and suppresses the invasive capacity of prostate cancer cells.

Authors:  Claire Hastie; John R Masters; Stephen E Moss; Soren Naaby-Hansen
Journal:  J Biol Chem       Date:  2008-01-22       Impact factor: 5.157

10.  MEK4 function, genistein treatment, and invasion of human prostate cancer cells.

Authors:  Li Xu; Yongzeng Ding; William J Catalona; Ximing J Yang; Wayne F Anderson; Borko Jovanovic; Kenji Wellman; Jaqueline Killmer; Xiaoke Huang; Karl A Scheidt; R Bruce Montgomery; Raymond C Bergan
Journal:  J Natl Cancer Inst       Date:  2009-07-28       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.